/ /

Dermatology

Insights to improve your psoriasis care planKnowledge of outcomes data, adverse events may help physicians formulate effective treatment strategies, Dr. April Armstrong says.
Coordinated care lessons in dermatologyCoordinated care is gaining ground in medicine because it helps defragment a fragmented system, says Dr. Lindsay Strowd. Patients with chronic conditions, such as psoriasis, tend to benefit most.
Risk-factors for actinic keratosis 12-month turnoverIdentifying associations with actinic keratosis variability instead of prevalence can be used to closely monitor organ transplant recipients at increased risk of developing actinic keratosis, researchers say.
Predictors for successful actinic keratosis treatmentStrong predictors for achieving a favorable actinic keratosis treatment response from ingenol mebutate 0.015% gel are dermoscopic detection of red pseudonetwork lesions and facial location, a study shows.
From new vaccines to the advent of new neurotoxinsPhysicians weigh in expectations for new developments within all facets of dermatology from pediatric dermatology to dermatopathology.
Methotrexate outperforms cyclosporine in atopic dermatitis studyThe duration of methotrexate administration proves to be longer than that of cyclosporine in atopic dermatitis, according to a small study that compared the two first-line immunosuppressive treatments for atopic dermatitis.
Ustekinumab shows promise for reducing psoriasis-associated cardiovascular comorbidityInitial results of an investigator-initiated phase 4 trial suggest that blocking interleukin-12 (IL-12) and IL-23 may reduce cardiovascular inflammation associated with psoriasis, researchers reported at AAD 2018.
Laddered treatment for pityriasis rubra pilarisDiagnosing PRP is challenging because it can mimic eczema, psoriasis, or even ichthyosis. Biologic treatment for refractory cases considered, researchers said at AAD 2018.
Switching biologic treatments in dermatologyNot all biologic treatments are equal. Side effects, effectiveness, cost and administration style are among factors physicians should consider when switching treatments, experts report at AAD 2018.
Strategic planningDermatologists must be aware of pending payment reductions and actively oppose Medicare's proposed elimination of global periods for certain procedures.